Advertisement
YOU ARE HERE: LAT HomeCollectionsGenentech

BRIEFLY

A West German firm bought 4.9% of Genentech.

March 01, 1985

Boehringer Ingelheim International, one of West Germany's largest drug companies, paid $40 million for 750,000 shares of the South San Francisco biotechnology company. The companies also said they are completing an agreement for Boehringer to commercialize a Genentech product in Europe. The product is a protein found in the human immune system that preliminary tests show may be able to kill cancer tumors without harming healthy cells. Boehringer specializes in cardiovascular and respiratory drugs.

Advertisement
Los Angeles Times Articles
|
|
|